Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antiatherogenic and Antimetabolic Effect of Curcumin Therapy in the Prevention and Delay of Type 2 Diabetic in Patients With Impaired Glucose Tolerance and Insulin Resistance

NCT01052025 is registered in ClinicalTrials.gov with Srinakharinwirot University as lead sponsor.

NCT NCT01052025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01052025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antiatherogenic and Antimetabolic Effect of Curcumin Therapy in the Prevention and Delay of Type 2 Diabetic in Patients With Impaired Glucose Tolerance and Insulin Resistance
Lead sponsor
Srinakharinwirot University
Phase
Phase 4
Overall status
Unknown status
Start date
August 31, 2009
Completion date
April 30, 2010
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular risk, insulin resistance, pre-diabetes, type 2 diabetes